Andrzej Kawecki
Overview
Explore the profile of Andrzej Kawecki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haddad R, Fayette J, Teixeira M, Prabhash K, Mesia R, Kawecki A, et al.
JAMA
. 2025 Mar;
PMID: 40079944
Importance: Treating locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) involves any combination of surgery, radiation, and chemotherapy, followed by routine monitoring for local recurrence or...
2.
Chaber-Ciopinska A, Kiprian D, Wieszczy P, Bielasik A, Bugajski M, Januszewicz W, et al.
Pol Arch Intern Med
. 2023 Mar;
133(10).
PMID: 36916462
Introduction: To date, there is no established optimal method for endoscopic detection of esophageal squamous cell neoplasia in high‑risk individuals. Objectives: We aimed to compare the performance of narrow‑band imaging...
3.
Haddad R, Harrington K, Tahara M, Ferris R, Gillison M, Fayette J, et al.
J Clin Oncol
. 2022 Dec;
41(12):2166-2180.
PMID: 36473143
Purpose: CheckMate 651 (ClinicalTrials.gov identifier: NCT02741570) evaluated first-line nivolumab plus ipilimumab versus EXTREME (cetuximab plus cisplatin/carboplatin plus fluorouracil ≤ six cycles, then cetuximab maintenance) in recurrent/metastatic squamous cell carcinoma of...
4.
Jarzab B, Dedecjus M, Lewinski A, Adamczewski Z, Bakula-Zalewska E, Baldys-Waligorska A, et al.
Endokrynol Pol
. 2022 May;
73(2):173-300.
PMID: 35593680
The guidelines Thyroid Cancer 2022 are prepared based on previous Polish recommendations updated in 2018. They consider international guidelines - American Thyroid Association (ATA) 2015 and National Comprehensive Cancer Network...
5.
Kapala A, Surwillo-Snarska A, Jodkiewicz M, Kawecki A
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34064057
The treatment of locally advanced head and neck cancer (HNC) is based on extensive resections followed by concurrent chemoradiotherapy (CRT) with platinum derivatives or concurrent radiotherapy with cetuximab (bioradiotherapy; BRT)....
6.
Pawlewicz K, Szutkowski Z, Kawecki A
Oncol Lett
. 2018 Feb;
15(3):3890-3894.
PMID: 29456738
Adenoid cystic carcinoma (ACC) of the trachea is a relatively rare tumor among thoracic diseases. The present study reports the case of a 23-year-old woman with ACC of the trachea...
7.
Gawelko J, Cierpial-Wolan M, Kawecki A, Wilk K, Pieciak-Kotlarz D, Sikorski D
Contemp Oncol (Pozn)
. 2017 Apr;
21(1):77-82.
PMID: 28435403
Aim Of The Study: To present the changes in the incidence of cancers of the head and neck organs in south-eastern Poland and in the whole country in the years...
8.
Kiprian D, Jarzabski A, Kawecki A
Contemp Oncol (Pozn)
. 2017 Apr;
20(5):389-393.
PMID: 28373821
Aim Of The Study: Oral mucositis is a common side effect of the oral mucosa due to anticancer therapy, especially for head and neck cancer. Caphosol is indicated for dryness...
9.
Szutkowski Z, Kawecki A, Jarzabski A, Laskus Z, Krajewski R, Michalski W, et al.
Rep Pract Oncol Radiother
. 2016 Oct;
21(6):537-543.
PMID: 27698593
Aim: The goal of this prospective study was to assess the effectiveness of a hypofractionated accelerated regime in treatment of the larynx cancer. Background: Multiple radiotherapy delivery regimes are used...
10.
Michalowska I, Cwikla J, Peczkowska M, Furmanek M, Buscombe J, Michalski W, et al.
Neuroendocrinology
. 2015 Mar;
101(4):321-30.
PMID: 25791839
Aims: The aim of this study was to assess the usefulness of somatostatin receptor scintigraphy (SRS) using (99m)Tc-[HYNIC, Tyr3]-octreotide (TOC) and 123I-metaiodobenzylguanidine (mIBG) in patients with SDHx-related syndromes in which...